Gunnar Öberg

A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony‐stimulating factor: significant effects on quality of life

Eva Hellström‐Lindberg, Nina Gulbrandsen, Greger Lindberg et al. · British Journal of Haematology · 2003 · 454 citations · Full text

Hematological Malignancy, Immunohematology, Laboratory Hematology +15

Treatment of Anemia in Myelodysplastic Syndromes With Granulocyte Colony-Stimulating Factor Plus Erythropoietin: Results From a Randomized Phase II Study and Long-Term Follow-Up of 71 Patients

Eva Hellström-Lindberg, Tomas Ahlgren, Yves Béguin et al. · Blood · 1998 · 306 citations · Full text

High-Dose Therapy and Autologous Stem-Cell Transplantation in Angioimmunoblastic Lymphoma: Complete Remission at Transplantation Is the Major Determinant of Outcome—Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Charalampia Kyriakou, Carmen Canals, Anthony P. Goldstone et al. · Journal of Clinical Oncology · 2007 · 153 citations

The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity

Moustapha Hassan, Per Ljungman, Olle Ringdén et al. · Bone Marrow Transplantation · 2000 · 148 citations

Pharmacological Study, 4-Hydroxy Metabolite, Medicine +6

High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients

Per Ljungman, Moustapha Hassan, AN Békássy et al. · Bone Marrow Transplantation · 1997 · 117 citations

Increased Transplant-related Mortality, Transplantation, Bone Marrow Failure +7